Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"?
(2001) American Journal of Kidney Diseases — Vol. 38, n° 5, p. E26 (2001)
Files
8978.pdf
Restricted Access - Adobe PDF
- 4.93 MB
Details
- Authors
- Abstract
- The causal role of aristolochic acid (AA) in the so-called Chinese herbs nephropathy (CHN) has been conclusively demonstrated only in the Belgian epidemic. We report a biopsy-proven hypocellular interstitial fibrosing nephropathy in a Chinese patient who had ingested a Chinese herbal preparation bought in Shanghai. The identification of AA in the preparation and of AA-DNA adducts in the kidney tissue unequivocally demonstrates, for the first time, the causal role of AA outside the Belgian epidemic. Because the ingested preparation is very popular in China as an over-the-counter product, our observation raises the possibility that many such cases due to AA might be currently unrecognized in China. AA should be banned from herbal preparations worldwide. All cases of the so-called CHN, in which the causal role of AA has been thoroughly documented, should be further identified as aristolochic acid nephropathy (AAN). The term phytotherapy-associated interstitial nephritis (PAIN) might refer to the other cases associated with phytotherapy without identification, as yet, of the causal agent.
- Affiliations
Citations
Gillerot, G., Jadoul, M., Arlt, V. M., Van Ypersele de Strihou, C., Schmeiser, H. H., But, P. P., Bieler, C. A., & Cosyns, J.-P. (2001). Aristolochic acid nephropathy in a Chinese patient: time to abandon the term “Chinese herbs nephropathy”? American Journal of Kidney Diseases, 38(5), E26. https://doi.org/10.1053/ajkd.2001.29576 (Original work published 2001)